Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is an exploratory study to compare activity and safety in 400 patients with previously
untreated metastatic carcinoma of the colon treated with UFOX (a combination regimen of UFT®
(Tegafur plus Uracil), Oxaliplatin, Folinic Acid) plus Cetuximab or FOLFOX-4 (a combination
regimen of 5 Fluorouracil (5-FU), Oxaliplatin and Folinic Acid) plus Cetuximab)